Convatec boosts full-year guidance, shares jump
18th May 2023 09:33
(Sharecast News) - Convatec Group boosted full-year revenue guidance on Thursday, following a strong start to the year.
Read moreConvatec buys anti-infection tech for initial £45m
19th Apr 2023 07:54
(Sharecast News) - Global medical products and technologies company Convatec said it had bought the anti-infective nitric oxide technology platform of 30 Technology Limited for an initial £45m.
Read moreConvatec posts 'good' full-year topline growth
9th Mar 2023 08:32
(Sharecast News) - Convatec posted "good" top-line growth and higher margins for 2022.
Read moreConvaTec raises FY outlook as YTD revenues improve
10th Nov 2022 08:04
(Sharecast News) - Medical products and technology firm Convatec upgraded its full-year guidance on Thursday as it reported group revenues had grown 2.4% on a reported basis over the ten months ended 31 October.
Read moreDirector dealings: ConvaTec non-exec makes £47k purchase
16th Aug 2022 15:36
(Sharecast News) - Wound care specialist ConvaTec Group was on the list of director buys on Tuesday, after a board member spent almost £50k in a transaction.
Read moreConvaTec confirms guidance after strong H1 revenue growth
4th Aug 2022 08:29
(Sharecast News) - ConvaTec reported "strong" revenue growth in its first half on Thursday, up 3.6% on a reported basis to $1.05bn, 8% on a constant currency basis, and 6.4% on an organic basis, with "positive performances" across all of its divisions.
Read moreRBC Capital Markets upgrades Convatec to 'sector perform'
18th May 2022 10:54
(Sharecast News) - Analysts at RBC Capital Markets upgraded medical products and technologies company Convatec from 'underperform' to 'sector perform' on Wednesday, stating further earnings downgrades appeared to be already priced in.
Read moreConvaTec YTD revenues rise amid 'good start' to 2022
12th May 2022 08:52
(Sharecast News) - Medical products and technologies company ConvaTec said on Thursday that group revenues had risen 4.1% in the four months ended 30 April on a constant currency basis as it made "a good start to the year", with solid underlying growth in each of its four categories.
Read moreConvaTec hikes dividend after strong revenue growth
8th Mar 2022 08:22
(Sharecast News) - ConvaTec reported "strong" revenue growth in its annual results on Tuesday, up 7.6% to $2.04bn (£1.56bn), driven by strength in advanced wound care and infusion care and modest growth in ostomy care and continence and critical care.
Read moreConvatec to acquire US-focussed Triad Life Sciences
28th Jan 2022 07:06
(Sharecast News) - Medical solutions firm Convatec has agreed to acquire US-focussed medical device company Triad Life Sciences in a deal worth as much as $275.0m.
Read moreConvatec hires Jonny Mason as next CFO
9th Dec 2021 08:05
(Sharecast News) - ConvaTec has hired former Dixons Carphone finance chief Jonny Mason as to replace Frank Schulkes as chief financial officer.
Read moreConvaTec sees organic revenue growth at upper end of guidance
29th Oct 2021 07:49
(Sharecast News) - Medical products company ConvaTec said on Friday that full-year organic revenue growth is set to be towards the upper end of its guidance range after an in-line third-quarter performance, which saw sales slow from the second quarter.
Read moreJPMorgan upgrades ConvaTec to 'overweight'
9th Sep 2021 09:51
(Sharecast News) - JPMorgan Cazenove upgraded medical products company ConvaTec to 'overweight' from 'neutral' on Thursday, lifting the price target to 272p from 229p as it pointed to an attractive entry point.
Read moreConvaTec confident despite margin pressures
30th Jul 2021 07:29
(Sharecast News) - Medical products company ConvaTec reported "strong" revenue growth ahead of expectations for its first half on Friday, with organic growth at 7.4%, or 7.0% on a constant currency basis to $1.01bn, with growth coming in at 11.0% on a reported basis.
Read moreThursday broker round-up
1st Jul 2021 13:45
(Sharecast News) - Ascential: Berenberg upgrades to buy with a target price of 485p.
Read more